Open AccessPrevalence and clinical outcomes of patients with apparent treatment‐resistant hypertension enrolled in Phase 2 cardiac rehabilitation
Author(s) -
Laffin Luke J.,
Khan Asad,
Lang Katherine,
Van Iterson Erik H.
Publication year - 2020
Publication title -
the journal of clinical hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 67
eISSN - 1751-7176
pISSN - 1524-6175
DOI - 10.1111/jch.14057
Subject(s) - medicine , rehabilitation , cohort , physical therapy , psychological intervention , psychiatry
Phase 2 cardiac rehabilitation (CR) employs evidenced‐based interventions to modify the risk of cardiac morbidity in its participants. The prevalence of apparent treatment‐resistant hypertension (aTRH) among CR participants is unknown. A retrospective analysis of a longitudinal cohort of patients who completed CR between 2012 and 2017 was undertaken. The prevalence of hypertension was 62% (n = 311). 11% of participants with hypertension had aTRH (n = 35). Participants with aTRH exhibited lower exercise capacity (EC) before starting CR and after its completion compared to normotensive counterparts ( P < .001). aTRH participants were more likely to experience a decrease in EC, even after participating in cardiac rehabilitation, compared to normotensive participants ( P = .02). aTRH participants were more likely to be hospitalized or seen in the emergency department after cardiac rehabilitation completion compared to normotensive counterparts (OR: 2.85, P < .01). CR presents an opportunity to identify and appropriately care for patients with aTRH.